Maravai LifeSciences Holdings

General Information
Business:

We are a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines, and to support research on human diseases. Our more than 5,000 customers as of Sept. 30, 2020 include the top 20 global biopharmaceutical companies ranked by research and development expenditures according to industry consultants, and many other emerging biopharmaceutical and life sciences research companies, as well as leading academic research institutes and in vitro diagnostics companies. Our products address the key phases of biopharmaceutical development and include complex nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.

(Note: Revenue and net income data shown here are for Topco LLC, the predecessor company, for the last 12 months. From the S-1 prospectus dated Oct. 29, 2020: “The selected consolidated financial data of Maravai LifeSciences Holdings, Inc. have not been presented as Maravai LifeSciences Holdings, Inc. is a newly incorporated entity, has had no business transactions or activities to date and had no material assets or liabilities during the periods presented in this section.”)

Industry: Pharmaceuticals
Employees: 390
Founded: 2014
Contact Information
Address 10770 Wateridge Circle Suite 200 San Diego, California 92121
Phone Number (858) 546-0004
Web Address http://www.maravai.com/
View Prospectus: Maravai LifeSciences Holdings
Financial Information
Market Cap $2075.19mil
Revenues $221.7 mil (last 12 months)
Net Income $59.4 mil (last 12 months)
IPO Profile
Symbol MRVI
Exchange NASDAQ
Shares (millions): 60.0
Price range $27.00 - $27.00
Est. $ Volume $1620.0 mil
Manager / Joint Managers Morgan Stanley/ Jefferies/ Goldman Sachs
CO-Managers BofA Securities/ Credit Suisse/ UBS Investment Bank/ Baird/ William Blair/ Stifel/ Keybanc Securities/ Academy Securities/ Loop Capital Markets/ Penserra Securities/ Tigress Financial Partners
Expected To Trade: 11/20/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change